NICE guidance on cost-saving drug not sought by DH

By Sarah Calkin2012-05-02T12:45:00

The Department of Health failed to act on expert advice to commission an appraisal of a drug which could lead to savings of £100m for the NHS, it has emerged.

You need to be signed in to read more

Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

All of HSJ.co.uk and our HSJ mobile app
News and insight on all areas of public funded healthcare
Expert commentary, insight and analysis from industry leaders
9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

to HSJ

Sign into your account here